Home > Financial Ratios > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Core EBITDA Growth

    Back to All Ratios
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

GUJARAT THEMIS BIOSYN Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -14.233.5929.1842.4329.97

What is the latest Core EBITDA Growth ratio of GUJARAT THEMIS BIOSYN ?

The latest Core EBITDA Growth ratio of GUJARAT THEMIS BIOSYN is -14.23 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-14.23
Mar20243.59
Mar202329.18
Mar202242.43
Mar202129.97

How is Core EBITDA Growth of GUJARAT THEMIS BIOSYN Trending?

Years Core EBITDA Growth % Change
Mar2025 -14.23
Negative
Mar2024 3.59
-87.70
Mar2023 29.18
-31.23
Mar2022 42.43
41.57
Mar2021 29.97 -

Other Financial Ratios of GUJARAT THEMIS BIOSYN


Compare Core EBITDA Growth ratio of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹3,102.7 Cr -4.3% -9.1% 12.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

-4.3%

-9.1%

12.6%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses